Lean Meds review
The rate a reader pays depends less on the dose than on how many months are paid for at once.
The verdict
Lean Meds publishes a standing month-to-month rate of $79 for compounded semaglutide and $109 for compounded tirzepatide, and a prepay ladder underneath both. The advertised $69 is the twelve-month rung, not the rate a reader pays in month one.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- $79/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Lean Meds is an online seller of compounded semaglutide and compounded tirzepatide, shipping to all fifty states, and what distinguishes its pricing page is that it shows the whole ladder rather than the bottom of it. Semaglutide runs $79 with nothing prepaid, $76 if three months are bought at once, $73 at six months and $69 at twelve. Tirzepatide steps the same way, from $109 month to month down through $105 and $100 to $95 on a year.
Who writes the prescription, and what do they see?
A prescription stands behind every rung on this ladder, and the pricing page is far more forthcoming about the rungs than about the person who writes it. That is the ordinary shape of the category rather than a failing peculiar to this seller, but it is the thing a reader buying a year up front has the least visibility into. How often a patient is reviewed across those twelve months, and by whom, is not something the priced row establishes.
Treatment is arranged remotely and the medication arrives by mail, which is the ordinary shape of this category and not a point of difference. The part that matters over a year is that the rate is flat across doses: a reader who starts at a low dose in month one and reaches a maintenance dose by month four is paying the same figure throughout. That is a different experience from a seller who reprices at each step of the titration, where the bill climbs at exactly the point the dose stops being easy.
What happens when the dose goes up?
The rate is flat across doses on both molecules, which means the month the dose stops being comfortable is not also the month the bill goes up. That is the part of a titration most sellers get wrong, and it is worth more over a year than the difference between two headline figures. The escalation itself still has to be managed by somebody, and what the seller offers in the way of a check-in at each step is not published beside the price. A reader who expects to move between molecules should note that the two ladders are $30 apart at every rung.
What the price includes
The decision a reader is actually making here is not which seller, but how much of a year to buy before knowing whether the treatment suits them. Twelve months of semaglutide at the $69 rung costs less per month than the $79 standing rate, and the gap over a year is real money. What it buys, though, is a commitment made in month one, before the side effects of the first escalation are known and before the plateau that usually arrives around month four. The month-to-month rate is the price of keeping that decision open.
What it claims, and what it cites
Both products are compounded rather than the manufacturer's approved pen, which means a pharmacy prepares them and no regulator reviews the finished vial before it ships. A reader who has seen the trial figures for semaglutide should know those came from the approved product at the doses on its label. Whether a compounded preparation performs the same way is not measured, and it is the part of this decision that no price comparison can settle.
Where it holds up, and where it does not
- Strength: Standing rate published beside prepay rungs
- Strength: Rate flat across the titration ladder
- Strength: Both molecules ship to fifty states
- Limitation: Lowest rate needs twelve months up front
- Limitation: Advertised figure is the prepaid rung
- Limitation: Tirzepatide costs $30 more than semaglutide
What the evidence says about this kind of treatment
The assessment above is about Lean Meds. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader weighing a month-to-month start against a year bought up front, because Lean Meds publishes both rungs on the same page rather than only the cheaper one.
- Wrong for
- A reader who wants the headline figure to be the first bill, since the $69 rate arrives only after twelve months are paid for in a single charge.
How Lean Meds compares
| Seller | Who it suits | Go |
|---|---|---|
| Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
 Embody | A reader willing to read the terms of service before the checkout total, because the low rate and the listed rate are different numbers. | See Embody → |
 Trimi Health | A reader who can pay a year at once, or finance it, and wants the per-month figure to stop moving as the dose rises. | See Trimi Health → |
More GLP-1 telehealth sellers reviews: PreventiveMDRevel HealthWholesome ClinicZera HealthBreeze MedsCare Bare Rx
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Why does this site rank Lean Meds on $79 rather than $69?
- Because $79 is what a reader pays in month one with nothing prepaid, and $69 is the rate that follows a twelve-month purchase. Both are real, and the boards here rank on the figure that does not require a commitment.
- Does the tirzepatide price move as the dose rises?
- Lean Meds states a flat rate across doses, so the monthly figure stays where it started through the escalation. The step that does move the bill is the choice between molecules, which is $30 a month at the standing rate.
- What happens if the treatment does not suit me in month two?
- That question is the whole argument for the month-to-month rung. A twelve-month purchase is made before the first escalation, before the side effects of it are known, and before the point where most people find out whether they will continue.
- Is Lean Meds expensive compared with other GLP-1 telehealth sellers?
- Lean Meds publishes a starting figure of $79/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts Lean Meds below the median, toward the cheaper end. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.